login
login

Europe Daily Bulletin No. 9949

28 July 2009
Contents Publication in full By article 27 / 37
GENERAL NEWS / (eu) eu/medicines

27/07/2009 (Agence Europe) - In a press release of 23 July, the European Medicines Agency announced that it had requested Sanofi-Aventis to continue research into a possible link between the use of certain insulin substitutes (lantus and optisulin) and an increased risk in cancer, particularly breast cancer. (O.J./trans/rh)

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION
WEEKLY SUPPLEMENT